Novel Coronavirus mRNA Vaccine
Prevention of COVID-19
ClinicalActive
Key Facts
About Zhifei Biological Products
Zhifei Biological Products is a major force in China's vaccine industry, with a mission to develop and provide high-quality, accessible vaccines to prevent infectious diseases. Its key achievements include the successful commercialization of a recombinant human papillomavirus (HPV) vaccine, a recombinant COVID-19 vaccine, and a portfolio of other preventive vaccines. The company's strategic direction focuses on leveraging its R&D and manufacturing capabilities to expand its product pipeline and solidify its domestic leadership while exploring international opportunities.
View full company profileTherapeutic Areas
Other Prevention of COVID-19 Drugs
| Drug | Company | Phase |
|---|---|---|
| Recombinant COVID-19 Vaccine (ZF2001) | Zhifei Biological Products | Approved |
| COVID-19 Inactivated Vaccine (BBIBP-CorV) | Tiantan Bio | Approved |
| Recombinant COVID-19 Vaccine | Tiantan Bio | Phase 3 |
| MVA-BN (Multi-Variant) | Bavarian Nordic | Phase 2 |
| Oral COVID-19 Vaccine | Oramed Pharmaceuticals | Pre-clinical |
| DMAb-1 | Inovio Pharmaceuticals | Phase 1 |
| DMAb-2 | Inovio Pharmaceuticals | Phase 1 |
| SARS-CoV-2 Vaccine | Auro Vaccines | Poised for Clinical |